Results In 12/30 cases (40%), the diagnosis of a hypertensive pregnancy disorder was
confirmed with an sFlt1/PlGF ratio of> 85. In 18/30 (60%) cases, a ratio< 85 excluded the …

Objective. To predict preeclampsia in pregnant women, by determining a ratio of soluble fms-
like tyrokinase-1 (sFlt-1) to placental growth factor (PlGF). For validation, 550 women were …

Background The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor
(PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its …

Preeclampsia is a pregnancy-associated condition, clinically characterized by hypertension,
proteinuria, and progressive edema, affecting 3% to 5% of all pregnancies. 1 Preeclampsia …

Background To evaluate the soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth
factor (PlGF), and sFlt-1/PlGF ratio for the prediction of early-and late-onset preeclampsia in …

Background It has been suggested that soluble fms-like tyrosine kinase receptor-1 (sFlt-1)
and placental growth factor (PlGF) play potential roles in preeclampsia diagnosis …

Objective To analyze the usefulness of a clinical protocol for early detection of preeclampsia
and/or fetal growth restriction (PE/FGR) using, in previously selected pregnancies, the …

Preeclampsia is characterized by angiogenic imbalance (AI), sFlt-1 (soluble fms-like tyrosine
kinase-1)/PlGF (placental growth factor) is useful for its diagnosis and prediction of adverse …

Preeclampsia is a multisystem hypertensive disorder and one of the leading causes of
maternal and fetal morbidity and mortality. The clinical hallmarks such as hypertension and …

Background To establish gestational specific cutoffs for the soluble fms-like tyrosine kinase-
1 (sFlt-1) and placental growth factor (PlGF) ratio as a diagnostic tool for pre-eclampsia (PE) …